Loading...
•
Dec 31, 2024
Bausch + Lomb Q4 2024 Earnings Report
Bausch + Lomb reported revenue growth across all segments and geographies in Q4 2024, with strong performance in vision care and surgical businesses.
Key Takeaways
Bausch + Lomb delivered broad-based growth in Q4 2024, with total revenue increasing 9% to $1.28 billion. The vision care segment led the way, supported by strong demand for contact lenses and consumer products. The company also reported a reduction in net loss and an increase in operating income, reflecting improved profitability.
Total revenue increased 9% year-over-year to $1.28 billion.
Net loss narrowed to $3 million from $54 million in Q4 2023.
Operating income improved to $87 million, up from $49 million in Q4 2023.
Strong performance in vision care and surgical segments drove revenue growth.
Bausch + Lomb
Bausch + Lomb
Bausch + Lomb Revenue by Segment
Revenue by Segment
Vision Care Revenue
CapyFin.comSurgical Revenue
CapyFin.comPharmaceuticals Revenue
CapyFin.com Forward Guidance
Bausch + Lomb expects continued growth in 2025, with revenue projected between $4.95 billion and $5.05 billion, supported by strong performance in core segments.
Positive Outlook
- Revenue growth expected in the range of 5.5% to 7.5% on a constant currency basis.
- Vision Care and Surgical segments continue to perform strongly.
- Acquisitions and product launches expected to drive growth.
- Investment in R&D to support long-term innovation.
- Improved operating leverage expected to enhance profitability.
Challenges Ahead
- Foreign exchange headwinds expected to reduce revenue by approximately $100 million.
- Adjusted EBITDA impacted by $20 million due to currency fluctuations.
- Higher selling and marketing expenses may weigh on margins.
- Macroeconomic uncertainties could impact consumer demand.
- Increased competition in key markets poses a risk to market share.
Revenue & Expenses
Visualization of income flow from segment revenue to net income